Alcidion Formally Launches Miya Precision as a New Kind of Technology for the NHS

Alcidion LtdA new type of technology for the NHS is expected to help re-energise the healthcare IT market, following the formal UK launch of Miya Precision by smart health tech company Alcidion.

Miya Precision integrates information from the healthcare organisation's current systems, uses it to automate routine tasks, care plans and pathways, and overlays existing data with advanced clinical decision support to make otherwise static information clinically valuable.

The new platform, which has been labelled as the very first smart clinical asset for the NHS, will provide hospitals and regions with a means to move beyond static electronic record systems to technology that proactively engages healthcare professionals.

The system will also immediately allow hospitals to realise clinical workflow benefits from clinical noting, natural language processing, electronic observations, electronic prescribing, flow management, mobility and more - to align with their digital strategies.

It will enable the NHS to quickly adopt new and emerging technologies and algorithms, as well as address strategic priorities. For example, integrated care systems are considering Miya Precision as an orchestration layer to join up disparate digital approaches and systems for hospitals across their regional footprint through a single smart interface. The platform does this by converting information in incumbent NHS systems to the FHIR standard - allowing that information to be applied to modern applications and to flow to appropriate users in a region.

Miya Precision has already seen early adoption in the NHS following successful use by organisations in other parts of the world and is expected to add significant value to existing electronic patient record strategies in the NHS. It will act as a core accelerator for trusts pursuing best of breed approaches to digitalisation.

Dartford and Gravesham NHS Trust is the first in the UK to sign up to Miya Precision. Neil Perry, director of digital transformation at the trust, said: "Miya Precision sits at the centre of our digital strategy. It provides a catalyst for us to harness digital technology in ways that allow our clinical staff to make informed decisions more easily, whilst focussing their time and efforts on delivering the best possible patient care and clinical outcomes. It is providing us with a new platform to become digitally mature, whilst leveraging artificial intelligence, natural language processing and many other advanced technologies. I look forward to sharing our approach with more hospitals considering this option."

Lynette Ousby, general manager for Alcidion in the UK, said: "We want to give the NHS a new option when it comes to technology that makes a difference to the way clinicians work. Miya Precision will automate care plans and pathways whilst relieving the cognitive burden still faced by healthcare professionals who very often still need to spend hours each day remembering to carry out hundreds of routine tasks.

"The NHS is faced with the challenge of delivering modern and engaging technology to clinicians whilst still needing to get value from its historic healthcare technologies. We believe we can offer an alternative to unlock that value, to join together systems and expose data in ways that really helps the people delivering care."

Alcidion is currently best known in the UK for its Patientrack early warning and electronic observations system. This system has helped hospitals in different parts of the UK to deliver a significant impact on patient safety by identifying and responding to the sickest patients and those at risk of deterioration. It has, for example, helped hospitals to deliver substantial reductions in cardiac arrests and to tackle deadly conditions including sepsis and acute kidney injury. As a more comprehensive solution, Miya Precision will help hospitals to build on this success and help to take technology adoption and patient safety in the NHS to the next level.

Dr Malcolm Pradhan, chief medical officer, for Alcidion, said: "Around the world the healthcare sector still expects doctors and nurses to perform acts of heroism every day just to get their job done. We believe IT systems should play a more active role in helping clinicians to look after their patients. Smart technology should help with the memory tasks so professionals can spend more time making difficult judgements - and then it should provide clinical decision support to aid in those decisions."

Alcidion Group managing director, Kate Quirke, said: "Formally launching Miya Precision for the NHS presents an opportunity for us to contribute to a history of world class excellence in enhancing patient care. The NHS is already Alcidion’s largest global partner of which we are immensely proud. We now look forward to using our full advanced product offering to help the health service accelerate its use of modern technology to support clinicians delivering care and to drive forward strategic priorities around interconnected and intelligent medicine."

About Alcidion

Alcidion Ltd (ASX:ALC) has a simple purpose, that is, to make healthcare better with smart, intuitive solutions that meet the needs of hospital and allied healthcare, worldwide. Alcidion incorporates three healthcare software companies previously known as Alcidion Corporation, Patientrack and OnCall and MKM Health, an IT solutions and services provider. Each company brings a complementary set of products and skills that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. With over 25 years of combined healthcare experience, the Alcidion Group of companies brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...